PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Chinese patients with advanced non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials
OncologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- World journal of surgical oncology
- Publicado em
- 10 jul 2025
- Citações
- 1
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone for Chinese patients with advanced non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized controlled trials
Jianfei Zhang, Min Liu, Dongyang Li, Jiali Luo, Min Wang
Descritores MeSH
- Immune Checkpoint Inhibitors
- Antineoplastic Combined Chemotherapy Protocols
- Lung Neoplasms
- B7-H1 Antigen
- Carcinoma, Non-Small-Cell Lung
- Survival Rate
- Randomized Controlled Trials as Topic
- Clinical Trials, Phase III as Topic
- Progression-Free Survival
- Programmed Cell Death 1 Receptor